Skip to main content
Equibles

UBS Group AG

Position in GRI — GRI Bio, Inc.

CIK 1610520 ZURICH, V8
Back to GRI Full portfolio

Position in GRI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,708
-$11,265 QoQ
Shares Held
4,920
-43.6% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 11 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GRI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. GRI ranks #454 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in GRI

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,708 4,920
2026-03-31 $19,973 8,722
2025-09-30 $55 27
2025-06-30 $19,936 15,455
2025-03-31 $10,383 3,245
2024-12-31 $76,397 92,267
2024-09-30 $25,864 71,647
2024-06-30 $34,492 17,965
2024-03-31 $6,095 8,021
2023-12-31 $921 2,394
2023-06-30 $3,901 899